欧洲细胞外基质市场预测至 2028 年 - COVID-19 影响和按原材料(牛、猪和其他原材料)、应用(软组织修复、硬脑膜修复、伤口愈合、心脏修复、心包修复和血管修复)进行的区域分析和重建)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 134    |    Report Code: TIPRE00027061    |    Category: Life Sciences

Europe Extracellular Matrix Market

欧洲细胞外基质市场预计将从 2021 年的 9,301.4 万美元增至 2028 年的 15,712.1 万美元。预计 2021 年至 2028 年该市场的复合年增长率为 7.8%。

肌肉骨骼疾病治疗的增加预计也将推动市场增长。研究表明,细胞外基质在治疗各种癌症方面具有积极的效果,因为它在抑制癌细胞的生长方面发挥着重要作用。大多数细胞行为和发育过程都是针对调节癌细胞的。因此,细胞外基质的好处能够有效地治疗癌症,并且越来越多的癌症病例可能需要细胞外基质。因此,由于上述因素,市场在预测期内可能会大幅增长。

疫情迫使研究机构和制药公司正在开发治疗 covid-19 的有效药物疗法,因此,预计市场在预测期内将出现缓慢增长。此外,由于全国范围内的封锁和限制,该地区的大多数外科手术被推迟和推迟,从而导致对细胞外基质衍生产品的需求不足。此外,COVID-19 的爆发可能会在预测期的初始阶段影响细胞外基质市场。由于全国范围内的封锁、伤口护理服务被拒绝、选择性手术推迟或取消、新疗法临床试验的延迟等。因此,预计疫情将对预测期内的市场增长产生负面影响。

借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动细胞外基质市场。预计欧洲细胞外基质市场在预测期内将以良好的复合年增长率增长。

欧洲细胞外基质市场收入和到 2028 年的预测(千美元)

欧洲细胞外基质市场细分

原材料

  • 其他< /span>

按应用

  • 软组织修复
  • 硬脑膜修复
  • 伤口愈合
  • 心脏修复
  • 心包修复
  • 血管修复与重建

按国家/地区

  • 欧洲
  • 德国
  • 英国
  • 法国
  • < span>西班牙
  • 意大利
  • 欧洲其他地区

提及的公司

  • 美敦力
  • 默克公司
  • Smith & Nephew
  • Anteris
  • 康乐保集团
  • 百特
  • 帝斯曼
  • 库克生物技术


Europe Extracellular Matrix Strategic Insights

Strategic insights for Europe Extracellular Matrix involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-extracellular-matrix-market-strategic-framework.webp
Get more information on this report

Europe Extracellular Matrix Report Scope

Report Attribute Details
Market size in 2021 US$ 9,301.4 thousand
Market Size by 2028 US$ 15,712.1 thousand
Global CAGR (2021 - 2028) 7.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 原料
  • 牛
  • 猪
  • 其他原料
By 应用
  • 软组织修复
  • 硬脑膜修复
  • 伤口愈合
  • 心脏修复
  • 心包修复
  • 血管修复与重建
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Medtronic
  • Merck Kgaa
  • Smith & Nephew
  • Anteris
  • Coloplast Group
  • Baxter
  • DSM
  • Cook Biotech
  • Get more information on this report

    Europe Extracellular Matrix Regional Insights

    The regional scope of Europe Extracellular Matrix refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-extracellular-matrix-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Extracellular Matrix Market

    1. Medtronic
    2. Merck Kgaa
    3. Smith & Nephew
    4. Anteris
    5. Coloplast Group
    6. Baxter
    7. DSM
    8. Cook Biotech   
    Frequently Asked Questions
    How big is the Europe Extracellular Matrix Market?

    The Europe Extracellular Matrix Market is valued at US$ 9,301.4 thousand in 2021, it is projected to reach US$ 15,712.1 thousand by 2028.

    What is the CAGR for Europe Extracellular Matrix Market by (2021 - 2028)?

    As per our report Europe Extracellular Matrix Market, the market size is valued at US$ 9,301.4 thousand in 2021, projecting it to reach US$ 15,712.1 thousand by 2028. This translates to a CAGR of approximately 7.8% during the forecast period.

    What segments are covered in this report?

    The Europe Extracellular Matrix Market report typically cover these key segments-

  • 原料 (牛, 猪, 其他原料)
  • 应用 (软组织修复, 硬脑膜修复, 伤口愈合, 心脏修复, 心包修复, 血管修复与重建)
  • What is the historic period, base year, and forecast period taken for Europe Extracellular Matrix Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Extracellular Matrix Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Extracellular Matrix Market?

    The Europe Extracellular Matrix Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medtronic
  • Merck Kgaa
  • Smith & Nephew
  • Anteris
  • Coloplast Group
  • Baxter
  • DSM
  • Cook Biotech
  • Who should buy this report?

    The Europe Extracellular Matrix Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Extracellular Matrix Market value chain can benefit from the information contained in a comprehensive market report.